POWERING BETTER PRODUCTS WITH NEXT GENERATION SYNTHETIC BIOLOGY
DEAD

Serial Number

85368484

Owner

INTREXON CORPORATION

Attorney

Doyle Siever

Filing Date

Jul 11, 2011

Add to watchlist:

No watchlists yet
View on USPTO

POWERING BETTER PRODUCTS WITH NEXT GENERATION SYNTHETIC BIOLOGY Trademark

Serial Number: 85368484

POWERING BETTER PRODUCTS WITH NEXT GENERATION SYNTHETIC BIOLOGY is a trademark filed by INTREXON CORPORATION on July 11, 2011. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services). The application is currently no longer active.

Owner Contact Info

INTREXON CORPORATION (92 trademarks)

1872 PRATT DRIVE, SUITE 1400
BLACKSBURG, VA 24060

Entity Type: 03

Trademark Details

Filing Date

July 11, 2011

Registration Date

Not Registered

Published for Opposition

October 2, 2012

Goods & Services

Custom manufacturing and custom synthesis of genetically engineered DNA, biological organisms, cells, viruses, pathogens and special purpose cells to the specifications of others for scientific, research, medical and laboratory use

Chemical preparations for medical and veterinary purposes, namely, proteins for use in treating disease states, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents; Chemical preparations for medical and veterinary purposes, namely, chemical preparations for gene therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for gene therapy analysis; biochemical preparations for medical and veterinary purposes, namely, biochemical preparations for gene therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for gene therapy analysis; Chemical inducers of gene expression in plants, mammals, fungi and bacteria for medical and veterinary applications; Chemicals and chemical reagents, namely, cells of transgenic animals, transgenic plants and transgenic fungi, and cells of animals, plants or fungi for use in medical, pharmaceutical and veterinary laboratory research; Pharmaceutical and veterinary preparations which regulate the cellular functions of fungi, plants, bacteria and mammals and transgenic fungi, plants, bacteria and mammals; transgenic fungi and bacteria for medical and veterinary purposes; Chemicals biochemicals and reagents for veterinary and medical use, namely, chemical, biochemicals and reagents for regulating, modifying or restricting gene expression, ligands, genetic vectors, genetic hosts, genetic biochemicals, genetic bioengineering reagents and proteins for use in regulating cellular functions, and gene expression inducers

Chemicals, biochemicals and reagents for use in industry and science; Chemicals for use in biochemical and chemical industry; chemicals for use in agriculture; chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparations for scientific purposes; chemical reagents for non-medical purposes; chemicals, biochemicals and reagents, namely, proteins for regulating, modifying or restricting gene expression, ligands, genetic vectors, genetic hosts, genetic biochemicals, genetic bioengineering reagents and proteins for use in regulating cellular functions in transgenic plants, fungi and animals, and in cells of plants, fungi and animals; Chemical inducers of gene expression in plants, mammals, fungi and bacteria for industrial and agricultural applications

Technology transfer services, namely, licensing and transfer of intellectual property

Medical services; Medical services, namely, gene therapy services

Development of new technology for others in the field of genetics, therapeutics and biotechnology; Development of products being genetic therapies and effectors to regulate, modulate, and characterize disease states; Development of tools in the nature of software and biotechnological processes to regulate, modulate, and characterize disease states; Research and development services for others in the fields of biotechnology and genetics, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use; Scientific research and product development services for others in the pharmaceutical, biotechnology, biosensors, bioelectronics, medical and agriculture fields; Gene therapy services for others for product development and scientific research purposes, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use

Filing History

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 18, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 18, 2020 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 18, 2020 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 18, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 18, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 18, 2020 COAR
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Dec 28, 2015 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 28, 2015 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 29, 2015 EXRA
SOU EXTENSION 5 GRANTED
May 28, 2015 EX5G
SOU EXTENSION 5 FILED
May 27, 2015 EXT5
SOU TEAS EXTENSION RECEIVED
May 27, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 26, 2014 EXRA
SOU EXTENSION 4 GRANTED
Nov 25, 2014 EX4G
SOU EXTENSION 4 FILED
Nov 24, 2014 EXT4
SOU TEAS EXTENSION RECEIVED
Nov 24, 2014 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 23, 2014 EXRA
SOU EXTENSION 3 GRANTED
May 22, 2014 EX3G
SOU EXTENSION 3 FILED
May 21, 2014 EXT3
SOU TEAS EXTENSION RECEIVED
May 21, 2014 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 15, 2014 EXRA
SOU EXTENSION 2 GRANTED
Jan 14, 2014 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 31, 2013 AITU
SOU EXTENSION 2 FILED
Nov 19, 2013 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 19, 2013 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 2, 2013 EXRA
SOU EXTENSION 1 GRANTED
Feb 28, 2013 EX1G
SOU EXTENSION 1 FILED
Feb 28, 2013 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 28, 2013 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 27, 2012 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 2, 2012 NPUB
PUBLISHED FOR OPPOSITION
Oct 2, 2012 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 12, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 28, 2012 PREV
ASSIGNED TO LIE
Aug 28, 2012 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 16, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 14, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 13, 2012 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 13, 2012 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 21, 2012 GNFN
FINAL REFUSAL E-MAILED
May 21, 2012 GNFR
FINAL REFUSAL WRITTEN
May 21, 2012 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 28, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 27, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 27, 2012 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 1, 2011 GNRN
NON-FINAL ACTION E-MAILED
Nov 1, 2011 GNRT
NON-FINAL ACTION WRITTEN
Nov 1, 2011 CNRT
ASSIGNED TO EXAMINER
Oct 25, 2011 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 14, 2011 NWOS
NEW APPLICATION ENTERED
Jul 14, 2011 NWAP